DNA methylation is a central mechanism of epigenetic regulation, influencing gene expression, genomic imprinting, and chromatin organization. Selecting the right analytical approach — sequencing-based or array-based, whole-genome or targeted, short-read or long-read — depends on your research question, sample type, and throughput requirements. CD Genomics provides a full spectrum of genome-wide DNA methylation analysis services across multiple platforms and methods.
Discuss Your Research Goals
Methylation Analysis
Methods Available
Lowest DNA Input
(5-Base / cfDNA)
Platform Types
(NGS, Array, Long-Read)
Sample Intake to
Data Report & Support
We offer a comprehensive range of sequencing-based methylation analysis methods — from whole-genome to targeted, short-read to long-read, and bisulfite to bisulfite-free — each optimized for specific research needs and sample types.
Single-base resolution across ~28–36 million CpG sites. Sodium bisulfite conversion enables gold-standard genome-wide 5mC profiling for comprehensive methylome discovery.
Best for: Full methylome characterization, biomarker discovery, non-model organisms.
MspI-based enrichment of CpG-dense regions covering ~3–7 million CpG sites. Enhanced double-RRBS protocol increases promoter and CpG island coverage.
Best for: Cost-effective methylation profiling, pilot studies, regulatory region analysis.
Antibody-based enrichment of methylated DNA fragments without bisulfite conversion. Region-based resolution suitable for genome-wide methylation scanning.
Best for: Large-sample screening, regional methylation pattern studies.
Nanopore-based direct detection of 5mC from native DNA without bisulfite or PCR. Resolves methylation in repetitive regions and segmental duplications.
Best for: Repeat-rich genomes, SV-methylation co-analysis, haplotype phasing.
Enzymatic 5mC→T conversion for dual detection of methylation and genetic variation (SNV/Indel/CNV/SV) from a single library. Works with 1 ng cfDNA or 50 ng gDNA.
Best for: Low-input samples (cfDNA, FFPE), dual-omic analysis, allele-specific methylation.
SMRT sequencing or enrichment-based N6-methyladenine (6mA) detection across the genome. Targets non-CG DNA modifications in prokaryotic and eukaryotic genomes.
Best for: Prokaryotic epigenetics, plant DNA methylation, non-CG modification research.
Methylation-sensitive restriction enzyme digestion combined with sequencing. Pairs with MeDIP-seq (M&M strategy) for complementary methylation profiles at reduced cost.
Hybrid-capture enrichment of CpG islands and promoter regions. High-depth analysis of ~2 million CpG sites in functionally critical regions for human and mouse.
Illumina Infinium methylation arrays provide cost-effective, high-throughput methylation profiling at predefined CpG sites. We offer three array options:
→ Explore Human DNA Methylation Microarray Services
The Infinium Mouse Methylation BeadChip covers >285,000 CpG sites across the mouse genome. We also offer mouse-specific CpG island microarray services for targeted analyses.
Beyond 5-methylcytosine (5mC), several cytosine modifications play distinct regulatory roles.
Detection of 5-formylcytosine via chemical labeling–assisted sequencing. Research-use only; literature-based method overview.
Antibody-based enrichment of 5-carboxylcytosine followed by sequencing. Research-use only.
TET-assisted pyridine borane sequencing for bisulfite-free 5mC detection. Literature-based method overview; method selection support.
Not sure which modification analysis fits your research? Share your sample type and study goals with us, and our epigenetics specialists will recommend the most suitable approach. Get Expert Advice
Sample quality and quantity directly affect data quality. Guidelines below are general references — share your sample type and project goals for a personalized assessment.
| Service | DNA Input (Recommended) | Concentration | Key QC Points |
|---|---|---|---|
| WGBS | ≥1 μg gDNA (min 200 ng) | ≥10 ng/µL | OD260/280: 1.8–2.0; DNA integrity by gel |
| RRBS | ≥1 μg gDNA (min 20 ng) | ≥20 ng/µL | MspI digestion efficiency verified |
| MeDIP-seq | ≥2 μg gDNA (min 1 μg) | ≥20 ng/µL | Enrichment efficiency by qPCR |
| 5-Base Sequencing | 50–100 ng gDNA / 1–20 ng cfDNA | ≥10 ng/µL | cfDNA: 166 bp peak; FFPE: DV200 >30% |
| Long-Read Methylation | ≥1 μg high-MW gDNA | ≥20 ng/µL | Fragment size >15 kb; no shearing |
| Methylation Array (Human) | 250–500 ng gDNA | ≥25 ng/µL | Bisulfite conversion efficiency ≥99% |
| Methylation Array (Mouse) | 250–500 ng gDNA | ≥25 ng/µL | Bisulfite conversion efficiency ≥99% |
This is a reference summary. Share your sample type, quantity, and research purpose with us, and we will help determine the most suitable method and sequencing strategy for your project. Send Your Sample Information
The general workflow follows a standardized pipeline with method-specific variations at the conversion step.
DNA methylation analysis services are supported by multiple sequencing and array platforms. The choice of platform depends on the method, throughput requirements, and desired data type.
| Platform | Application | Used For |
|---|---|---|
| Illumina NovaSeq 6000 / NovaSeq X | High-throughput short-read sequencing | WGBS, RRBS, MeDIP-seq, 5-base sequencing, CpG island panel sequencing |
| Illumina iScan | Array scanning | Infinium methylation arrays (270K, 850K/EPIC, 935K/EPIC v2; mouse BeadChip) |
| Oxford Nanopore (GridION / PromethION) | Long-read direct sequencing | Direct 5mC detection, repeat-region methylation analysis |
| PacBio Sequel II / Revio | SMRT long-read sequencing | DNA 6mA detection, native base modification analysis |
| Qubit / Fragment Analyzer / Bioanalyzer | QC instrumentation | DNA quantification and integrity assessment across all methods |
For targeted enrichment applications, we use hybrid-capture systems compatible with both bisulfite-converted and native DNA libraries.
DNA methylation data analysis is structured to support publication-ready results. All services include the following core deliverables and analysis modules.
Standard Deliverables per Sample: Raw FASTQ (or IDAT for arrays), QC report, aligned data (BAM), methylation calls (beta values or methylation level matrices), data summary report (PDF).
| Module | Content | Applies To |
|---|---|---|
| Data QC | Quality scores, GC content, adapter contamination, duplication rates | Sequencing-based services |
| Alignment | Reference genome alignment, conversion rate estimation | Sequencing-based services |
| Methylation Calling | Per-site methylation level, CpG/CHG/CHH context stratification | WGBS, RRBS, 5-base, BS-seq |
| Peak Calling | Methylated region identification from enrichment data | MeDIP-seq, hMeDIP-seq |
| Differential Methylation | DMC/DMR identification, region annotation, statistical testing | All methods (with replicates) |
| Functional Annotation | GO enrichment, KEGG pathway analysis of DMR-associated genes | All methods |
| PCA / Clustering | Sample-level correlation, MDS/PCA plots, hierarchical clustering | All methods (multi-sample) |
| Visualization | Methylation heatmaps, browser tracks, Circos plots, lollipop diagrams | All methods |
Optional Advanced Analysis: Allele-specific methylation analysis, epigenetic clock / biological age estimation, multi-omics integration (RNA-seq + methylation), fragmentomic analysis (cfDNA), custom reporting.
Below are representative examples of DNA methylation data analysis outputs from our service. Actual results vary by method, sample quality, and sequencing depth.
DNA methylation profiling identifies tumor suppressor silencing, oncogene hypomethylation, and cancer-type-specific methylation signatures. Applications include liquid biopsy biomarker development, tumor subtyping, and treatment response monitoring.
Epigenetic clocks based on age-associated CpG methylation changes enable biological age estimation, healthspan assessment, and intervention evaluation.
Characterizes methylation changes induced by environmental exposures (pollutants, diet, stress) and their transgenerational inheritance.
DNA methylation dynamics during embryogenesis, cell differentiation, and tissue specification are central to understanding developmental programming.
Epigenome-wide association studies with thousands of samples benefit from the cost-efficiency of methylation arrays or RRBS.
Methylation profiling in agricultural species, evolutionary biology, and ecology, with reference-free analysis where needed.
There is no single best approach — the optimal method depends on your research question, sample type, throughput, and budget.
| Dimension | WGBS | RRBS | MeDIP-seq | 5-Base | Long-Read (ONT) | Array (EPIC) |
|---|---|---|---|---|---|---|
| Resolution | Single-base | Single-base | Region-based | Single-base | Single-base | Single-base (targeted) |
| CpG Coverage | ~28M | ~3–7M | Enriched peaks | ~28M | Unique in repeats | ~935K targeted |
| DNA Input | 200 ng–1 μg | 20 ng–1 μg | 1–2 μg | 1 ng–100 ng | ≥1 μg (HMW) | 250–500 ng |
| Bisulfite-Free | No | No | Yes | Yes (enzymatic) | Yes (direct) | No |
| Variant Detection | Limited | Limited | No | SNV/Indel/CNV/SV | SNV/SV | No |
| Best For | Full methylome discovery | CpG-rich regions | Large-scale screening | Low-input dual-omics | Repetitive regions | Large cohort EWAS |
Start with your sample — Limited DNA? Prioritize 5-base or arrays. High-MW gDNA with repeat concerns? Consider long-read.
Match resolution to question — Discovery needs WGBS/5-base. CpG islands need RRBS or panels.
Consider throughput — Large cohorts benefit from arrays or RRBS. Single-sample discovery needs WGBS/5-base.
Need dual-omic data? — 5-base sequencing is the only single-assay solution for methylation + variant co-detection.
"The DNA methylation analysis services have been instrumental in our cancer epigenetics research. Having access to both WGBS and array options under one service team made it straightforward to match methods to different phases of our study — discovery with WGBS, validation with arrays. The bioinformatics support was particularly helpful for interpreting the large datasets."
— Principal Investigator, Cancer Epigenetics Lab, Academic Medical Center
"We use RRBS routinely for our environmental epigenetics cohort studies — hundreds of samples per project. The consistency of data across batches and the detailed QC reporting give us confidence in our cross-study comparisons. The double RRBS protocol has noticeably improved CpG coverage in promoter regions."
— Associate Professor, Environmental Health Sciences, Research University
"We needed long-read methylation analysis for a repeat-rich plant genome, and the Nanopore service delivered data that short-read bisulfite sequencing could not map. The technical team helped optimize the DNA extraction to meet the high-MW requirement, and the final data quality exceeded our expectations."
— Research Group Leader, Plant Epigenetics, Agricultural Research Institute
The following publications cite DNA methylation analysis services provided by CD Genomics, demonstrating the application of our services across diverse research areas.
Publication list reflects CD Genomics-supported studies. For a full list, visit our Publications page.
Genome-wide profiling of super-enhancer-associated regulatory regions using ChIP-seq and H3K27ac analysis.
Genome-wide 5hmC profiling using hMeDIP-seq, oxBS-seq, and 5hmC-SEAL-seq.
Focused methylation analysis using bisulfite sequencing PCR, targeted EM-seq, and custom gene panels.
Custom bioinformatics for epigenomic datasets, including peak calling, differential analysis, and multi-omics integration.
Cell-free DNA methylation sequencing for liquid biopsy, including WGBS, EM-seq, and panel-based approaches.
Mass spectrometry-based quantification of global DNA and RNA modification levels.
For Research Use Only. Not for use in diagnostic procedures. CD Genomics provides DNA methylation analysis services exclusively for research purposes. Service parameters, platform availability, and bioinformatics analysis modules are subject to project-specific optimization. The mention of third-party trademarks (Illumina, NovaSeq, Infinium, Oxford Nanopore, PacBio) is for informational purposes only.
Last updated: June 2026
Terms & Conditions Privacy Policy Copyright © CD Genomics. All rights reserved.
Quote Request


